โรงพยาบาลพระมงกุฎเกล้า เป็นโรงพยาบาลทั่วไป ขนาด 1,200 เตียง ตามอัตราการจัดเฉพาะกิจที่ 3600 มีภารกิจดังต่อไปนี้ 1. ให้บริการทางการแพทย์แก่ทหาร รวมไปถึงครอบครัว และประชาชน 2. จัดฝึกศึกษาให้นักเรียนแพทย์ทหาร นักเรียนพยาบาล แพทย์ประจำบ้าน และตลอดจนบุคลากรทางการแพทย์ทุกระดับ 3.

During the past decade, Phramongkutklao Hospital conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 18 clinical trials were completed, i.e. on average, 43.9% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 13 clinical trials were completed. i.e. 72.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Phramongkutklao Hospital" #1 sponsor was "Phramongkutklao College of Medicine and Hospital" with 5 trials, followed by "Allergan" with 4 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Apellis Pharmaceuticals, Inc." with 3 trials sponsored and "Danone Asia Pacific Holdings Pte, Ltd." with 3 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Phramongkutklao Hospital" #1 collaborator was "Navitas Life Sciences GmbH" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "BeiGene, Ltd." with 1 trials as a collaborator, "Danone Research" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Phramongkutklao Hospital" are "Gastroparesis" (4 trials), "Dengue" (3 trials), "Diabetes Mellitus" (3 trials), "Atrial Fibrillation" (2 trials) and "Chronic Hepatitis" (2 trials). Many other conditions were trialed in "Phramongkutklao Hospital" in a lesser frequency.

Most popular intervention types in "Phramongkutklao Hospital" are "Drug" (39 trials), "Other" (8 trials), "Biological" (5 trials), "Device" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Relamorelin" (3 trials), "Adefovir" (2 trials), "Clevudine" (2 trials) and "EPIAO®" (2 trials). Other intervention names were less common.

The vast majority of trials in "Phramongkutklao Hospital" are 54 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Phramongkutklao Hospital". undefined are not yet recruiting, 11 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Phramongkutklao Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Phramongkutklao Hospital, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 5 trials that are defined as “Not Applicable".